Intrapericardial delivery of cardiosphere-derived cells: An immunological study in a clinically relevant large animal model

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Blázquez, Rebeca ^a   Sánchez Margallo, Francisco Miguel ^a   Crisóstomo, Verónica ^a   Báez, Claudia ^a   Maestre, Juan ^a   Álvarez, Verónica ^a   Casado, Javier G ^a  

^a JESÚS USÓN MINIMALLY INVASIVE SURGERY CENTRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ATAXIN 1; BETA1 INTEGRIN; BETA3 INTEGRIN; CD31 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARDIOSPHERE DERIVED CELL TRANSPLANTATION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDDIASTOLIC VOLUME; ENDSYSTOLIC VOLUME; GENE EXPRESSION; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART VOLUME; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; SAFETY; YORKSHIRE PIG; ADIPOCYTE; ANIMAL; BONE DEVELOPMENT; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CHONDROCYTE; CYTOLOGY; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERICARDIUM; PHENOTYPE; PIG; POLYMERASE CHAIN REACTION; PROCEDURES; REGENERATION; STEM CELL TRANSPLANTATION;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CHONDROCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; OSTEOGENESIS; PERICARDIUM; PHENOTYPE; POLYMERASE CHAIN REACTION; REGENERATION; STEM CELL TRANSPLANTATION; SWINE;

EID: 84959419244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149001     Document Type: Article

References (55)

1. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011; 109: 923-940. doi: 10.1161/CIRCRESAHA.111.243147 PMID: 21960725
2. Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. Bio Med Res Int. 2013; 2013: 547902. doi: 10.1155/2013/547902 PMID: 23509740
3. Mazo M, Gavira JJ, Pelacho B, Prosper F. Adipose-derived stem cells for myocardial infarction. J Cardiovasc Transl Res. 2011; 4: 145-153. doi: 10.1007/s12265-010-9246-y PMID: 21116883
4. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (Safe Cell): a systematic review and meta-analysis of clinical trials. PloS One. 2012; 7: e47559. doi: 10.1371/journal.pone.0047559 PMID: 23133515
5. Trivedi P, Tray N, Nguyen T, Nigam N, Gallicano GI. Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. Stem Cells Dev. 2010; 19: 1109-1120. doi: 10.1089/scd.2009.0465 PMID: 20092388
6. Hoogduijn MJ, Roemeling-van Rhijn M, Korevaar SS, Engela AU, Weimar W, Baan CC. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Hum Gene Ther. 2011; 22: 1587-1591. doi: 10.1089/hum.2011.039 PMID: 21732766
7. Gebler A, Zabel O, Seliger B. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med. 2012; 18: 128-134. doi: 10.1016/j.molmed.2011.10.004 PMID: 22118960
8. Huang NF, Lam A, Fang Q, Sievers RE, Li S, Lee RJ. Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med. 2009; 4: 527-538. doi: 10.2217/rme.09.32 PMID: 19580402
9. Fukushima S, Sawa Y, Suzuki K. Choice of cell-delivery route for successful cell transplantation therapy for the heart. Future Cardiol. 2013; 9: 215-227. doi: 10.2217/fca.12.85 PMID: 23463974
10. Blázquez R, Sánchez-Margallo FM, Crisóstomo V, Báez C, Maestre J, García-Lindo M, et al. Intrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysis. PloS One. 2015; 10: e0122377. doi: 10.1371/journal.pone.0122377 PMID: 25816232
11. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-921. PMID: 15472116
12. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, et al. Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens. Circulation. 2007; 115: 896-908. PMID: 17283259
13. Johnston PV, Sasano T, Mills K, Evers R, Lee S-T, Smith RR, et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009; 120: 1075-1083. doi: 10.1161/CIRCULATIONAHA.108.816058 PMID: 19738142
14. Kanazawa H, Tseliou E, Malliaras K, Yee K, Dawkins JF, De Couto G, et al. Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circ Heart Fail. 2015; 8: 322-332. doi: 10.1161/CIRCHEARTFAILURE.114.001484 PMID: 25587096
15. Suzuki G, Weil BR, Leiker MM, Ribbeck AE, Young RF, Cimato TR, et al. Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium. PloS One. 2014; 9: e113009. doi: 10.1371/journal.pone.0113009 PMID: 25402428
16. Lee S-T, White AJ, Matsushita S, Malliaras K, Steenbergen C, Zhang Y, et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol. 2011; 57: 455-465. doi: 10.1016/j.jacc.2010.07.049 PMID: 21251587
17. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet. 2012; 379: 895-904.
18. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, et al. Intracoronary cardiospherederived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventric Ular dySfunction). J Am Coll Cardiol. 2014; 63: 110-122. doi: 10.1016/j.jacc.2013.08.724 PMID: 24036024
19. Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2015; 116: 653-664. doi: 10.1161/CIRCRESAHA.116.304671 PMID: 25403163
20. Smith RR, Marbán E, Marbán L. Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel. Biomatter. 2013; 3: e24490. doi: 10.4161/biom.24490 PMID: 23538511
21. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997; 64: 295-312. PMID: 9027589
22. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147. PMID: 10102814
23. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 1998; 4: 415-428. PMID: 9916173
24. Kelley KW, Curtis SE, Marzan GT, Karara HM, Anderson CR. Body surface area of female swine. J Anim Sci. 1973; 36: 927-930. PMID: 4703721
25. Kwon Y-W, Yang H-M, Cho H-J. Cell Therapy for Myocardial Infarction. Int J Stem Cells. 2010; 3: 8-15. PMID: 24855535
26. Wollert KC, Drexler H. Clinical Applications of Stem Cells for the Heart. Circ Res. 2005; 96: 151-163. PMID: 15692093
27. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013; 113: 810-834. doi: 10.1161/CIRCRESAHA.113.300219 PMID: 23989721
28. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006; 27: 1114-1122. PMID: 16510464
29. Dib N, Khawaja H, Varner S, McCarthy M, Campbell A. Cell therapy for cardiovascular disease: a comparison of methods of delivery. J Cardiovasc Transl Res. 2011; 4: 177-181. doi: 10.1007/s12265-010-9253-z PMID: 21181320
30. Van Ramshorst J, Rodrigo SF, Schalij MJ, Beeres SLMA, Bax JJ, Atsma DE. Bone marrow cell injection for chronic myocardial ischemia: the past and the future. J Cardiovasc Transl Res. 2011; 4: 182-191. doi: 10.1007/s12265-010-9249-8 PMID: 21213093
31. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet. 2011; 378: 1847-1857.
32. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012; 126: S54-64. PMID: 22965994
33. Ladage D, Turnbull IC, Ishikawa K, Takewa Y, Rapti K, Morel C, et al. Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model. Gene Ther. 2011; 18: 979-985. doi: 10.1038/gt.2011.52 PMID: 21512506
34. Yang Y, Dreessen de Gervai P, Sun J, Glogowski M, Gussakovsky E, Kupriyanov V. MRI studies of cryoinjury infarction in pig hearts: II. Effects of intrapericardial delivery of adipose-derived stem cells (ADSC) embedded in agarose gel. NMR Biomed. 2012; 25: 227-235. doi: 10.1002/nbm.1735 PMID: 21774011
35. Burr SP, Dazzi F, Garden OA. Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? Immunol Cell Biol. 2013; 91: 12-18. doi: 10.1038/icb.2012.60 PMID: 23146942
36. Björkström NK, Gonzalez VD, Malmberg K-J, Falconer K, Alaeus A, Nowak G, et al. Elevated Numbers of FcγRIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection. J Immunol. 2008; 181: 4219-4228. PMID: 18768879
37. Denyer MS, Wileman TE, Stirling CMA, Zuber B, Takamatsu H-H. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet Immunol Immunopathol. 2006; 110: 279-292. PMID: 16325923
38. De Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, et al. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015; 125: 3147-3162. doi: 10.1172/JCI81321 PMID: 26214527
39. Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J. Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol. 1994; 104: 48-56. PMID: 7950405
40. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009; 94: 173-184. doi: 10.3324/haematol.13740 PMID: 19066333
41. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Ménez A, Le Du MH. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem. 2001; 276: 31171-31178. PMID: 11395499
42. O'Connor MD, Kardel MD, Iosfina I, Youssef D, Lu M, Li MM, et al. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells. 2008; 26: 1109-1116. doi: 10.1634/stemcells.2007-0801 PMID: 18276800
43. Lee D-H, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006; 27: 2170-2176. PMID: 16772340
44. Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol. 2013; 18: 53-56. PMID: 24294039
45. Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, et al. Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens. 2007; 25: 2497-2503. PMID: 17984672
46. Poelzl G, Eberl C, Achrainer H, Doerler J, Pachinger O, Frick M, et al. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure. Circ Heart Fail. 2009; 2: 294-302. doi: 10.1161/CIRCHEARTFAILURE.108.826735 PMID: 19808352
47. Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 2007; 28: 33-38. PMID: 17126601
48. Ege T, Canbaz S, Yuksel V, Duran E. Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. Cytokine. 2003; 23: 47-51. PMID: 12901854
49. Pankuweit S, Wädlich A, Meyer E, Portig I, Hufnagel G, Maisch B. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz. 2000; 25: 748-754. PMID: 11200123
50. Nian M, Lee P, Khaper N, Liu P. Inflammatory Cytokines and Postmyocardial Infarction Remodeling. Circ Res. 2004; 94: 1543-1553. PMID: 15217919
51. Brassard DL, Grace MJ, Bordens RW. Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol. 2002; 71: 565-581. PMID: 11927642
52. Boonen A, Stockbrügger RW, van der Linden S. Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol. 1999; 18: 177-179. PMID: 10357129
53. Gressens B, Gohy P. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastro-Enterol Belg. 2004; 67: 301-302.
54. Popescu C, Arama V, Gliga S. Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis-case report. BMC Gastroenterol. 2011; 11: 30. doi: 10.1186/1471-230X-11-30 PMID: 21453456
55. Malliaras K, Smith RR, Kanazawa H, Yee K, Seinfeld J, Tseliou E, et al. Validation of contrastenhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013; 128: 2764-2775. doi: 10.1161/CIRCULATIONAHA.113.002863 PMID: 24061088